Portal de Periódicos da CAPES

STUDIES OF THE NONSPECIFIC INACTIVATION OF NEWCASTLE DISEASE VIRUS BY MAMMALIAN SERA*

1960; Wiley; Volume: 83; Issue: 4 Linguagem: Inglês

10.1111/j.1749-6632.1960.tb40928.x

1749-6632

David T. Karzon, Robert H. Bussell,

Viral Infections and Vectors

Annals of the New York Academy of SciencesVolume 83, Issue 4 p. 539-550 STUDIES OF THE NONSPECIFIC INACTIVATION OF NEWCASTLE DISEASE VIRUS BY MAMMALIAN SERA* David T. Karzon, Corresponding Author David T. Karzon Department of Pediatrics and of Bacteriology and Immunology University of Buffalo School of Medicine, Buffalo, N. Y.Scholar in Medical Science of the John and Mary R. Markle Foundation, New York, N. Y.Search for more papers by this authorRobert H. Bussell, Robert H. Bussell Department of Pediatrics, University of Buffalo School of Medicine, Buffalo, N. Y.Search for more papers by this author David T. Karzon, Corresponding Author David T. Karzon Department of Pediatrics and of Bacteriology and Immunology University of Buffalo School of Medicine, Buffalo, N. Y.Scholar in Medical Science of the John and Mary R. Markle Foundation, New York, N. Y.Search for more papers by this authorRobert H. Bussell, Robert H. Bussell Department of Pediatrics, University of Buffalo School of Medicine, Buffalo, N. Y.Search for more papers by this author First published: January 1960 https://doi.org/10.1111/j.1749-6632.1960.tb40928.xCitations: 5 * The work reported in this paper was supported in part by Grant No. E-503 from the National Institute of Allergy and Infectious Diseases, Public Health Service, Bethesda, Md. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pillemer, L., L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd & A. C. Wardlaw 1954. The properdin system and immunity I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 120: 279–285. 2 Wedgwood, R. J., H. S. Ginsberg & L. Pillemer 1956. The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J. Exptl. Med. 104: 707–725. 3 Cowan, K. M. 1958. Interpretation of properdin levels determined by phasge neutralization technique. Science. 128: 778–779. 4 Nelson, R. A. Jr. 1958. An alternative mechanism for the properdin system. J. Exptl. Med. 108: 515–535. 5 Pernis, B. & M. Turri 1958. Osservazioni sul dosaggio della proerdina mediante la neutralizzazione del bacteriofago. Boll. Istit. Sieroterap. Milan. 37: 414–424. 6 Barlow, T. L., H. Van Vunakis & L. Levine 1958. Studies of the inactivation of phage by the properdin system I. Evidence for complement, properdin, and magnesium requirements. J. Immunol. 80: 339–348. 7 Barlow, J. L., H. Van Vunakis & L. Levine 1958 Studies of the inactivation of phage by the properdin system. II. Quantitative assay of phage-neutralizing activity. J. Immunol. 80: 349–355. 8 Karzon, D. T. 1956. Non-specific viral inactivating substance (VIS) in human and mammalian sera. Natural antagonists to the inactivator of Newcastle disease virus and observations on the nature of the union between the inactivator and virus. J. Immunol. 76: 454–463. 9 Dulbecco, R., M. Vogt & A. G. R. Strickland 1956. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus, and poliomyelitis virus. Virology. 2: 162–205. 10 Fazekas De, St., Groth, S. & A. F. Reid 1958. The neutralization of animal viruses II. A critical comparison of hypotheses. J. Immunol. 80: 225–235. 11 Pillemer, L., M. D. Schoenberg, L. Blum & L. Wurz 1955. Properdin system and immunity II. Interaction of the properdin system with polysaccharides. Science. 122: 545–549. 12 Pillemer, L., M. Landy & M. J. Shear 1957. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides. J. Exptl. Med. 106: 99–110. 13 Bang, F. B., M. Foard & D. T. Karzon 1951. Mode of action of heat-labile serum inactivating substance on Newcastle disease virus. Bull. Johns Hopkins Hosp. 88: 83–100. 14 Pillemer, L., L. Blum, I. H. Lepow, L. Wurz & E. W. Todd 1956. The properdin system and immunity. III. The zymosan assay of properdin. J. Exptl. Med. 103: 1–13. 15 Osler, A. G., J. H. Strauss & M. M. Mayer 1952. Diagnostic complement fixation I. A method. Am. J. Syphilis, Gonorrhea, Venereal Diseases. 36: 140–153. 16 Von Krogh, M. 1916. Colloidal chemistry and immunology. J. Infectious Diseases. 19: 452–477. 17 Shimizu, T., R. Ishizaki, Y. Kono, T. Kumagai, S. Araj, J. Sasahara, S. Ishii & M. Matumoto 1955. Multiplication of and cytopathogenic effect of “the hemagglutinating virus of Japan” (HVJ) in swine kidney and tissue culture. Japan J. Exptl. Med. 26: 211–222. 18 Heller, L., A. Espmark & P. Viriden 1956. Immunological relationship between infectious cough in horses and human influenza A. Arch. ges. Virusforsch. 7: 120–124. 19 Cook, M. K., B. E. Andrews, H. H. Fox, H. C. Turner, W. D. James & R. M. Chanock 1959. Antigenic relationships among the “newer” myxoviruses (parainfluenza). Am. J. Hyg. 69: 250–264. 20 Abinanti, F. R. & R. J. Huebner 1959. The serological relationships of strains of parainfluenza 3 virus isolated from humans and cattle with respiratory disease. Virology. 8: 391–394. 21 Noice, F., F. M. Bolin & D. F. Eveleth 1959. Incidence of viral parotitis in the domestic dog. A. M. A. J. Diseases Children. 98: 350–352. 22 Wedgwood, R. J. 1957. Inhibition of the bactericidal activity of the properdin system with specific bacterial antibodies (abstr.). J. Clin. Invest. 36: 935. 23 Pillemer, L., C. F. Hinz, Jr. & L. Wurz 1957. Preparation and properties of antihuman properdin rabbit serum. Science. 125: 1244–1245. Citing Literature Volume83, Issue4Inactivation of VirusesJanuary 1960Pages 539-550 ReferencesRelatedInformation